Loading
GS
Grifols, S.A Stock: price and insider trades · Spain
No insider purchase over the last 90 days. The latest, by THOMAS GLANZMANN, was filed 07 Sept 2020.
Grifols, S.A: what insiders have been doing
Grifols, S.A is a Health Care company. Its directors and officers file their transactions with CNMV. Grifols, S.A has had no insider filing for more than a year; the last one goes back to 25 May 2021.
Since 2020, the database holds 4 purchases and 3 sales by insiders of the company.
Source: insider filings from CNMV. Past trades are no guide to future returns.
Insider Decl.
11
Thresholds
n/a
Buy Volume
€258,960
4 ops. · all time
Sell Volume
€748,567
3 ops. · all time
Analyst consensus: bullish or bearish?
Analysts rate Grifols, S.A Buy (bullish), based on 8 analysts. Average price target: €21.32.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 10,944 of 26,284 companies
55.8
score / 100
Value69
Quality43
FCF yld9.5%
Earn yld6.1%
EV/EBITDA9.8x
ROE·
Gross mgn38%
Net mgn5.3%
Debt/EBITDA5.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€6.85
Analyst consensus
8 analystsBuy
€18.00Target €21.32(+211%)€25.50
Income statement
Revenue€7.5B
Gross profit€2.9B38% margin
EBITDA€1.6B22% margin
Net income€402.0M5.3% margin
Balance sheet & cash
Market cap€6.5B
Total debt€9.6B
Free Cash Flow€624.0M
Last declaration on 25 May 2021
Declarations11 total
3,464 shares@ €15.40100.0% of flowShareXXXXISIN ES0171996095CNMV:2021076188
2,200 shares@ €21.85ShareXXXXISIN ES0171996087CNMV:2020094979
Canonical exit: 6 Dec 2020 (T+90)
7,500 shares@ €13.28ShareXXXXISIN ES0171996095CNMV:2020094980
Canonical exit: 6 Dec 2020 (T+90)
775,220 shares@ €24.60ShareXXXXISIN ES0171996087CNMV:2020086601
22,341 shares@ €15.28ShareBBVAISIN ES0171996095CNMV:2020059770
12,567 shares@ €15.28ShareXMADISIN ES0171996095CNMV:2020059794
22,341 shares@ €15.28ShareXMADISIN ES0171996095CNMV:2020059803
500 shares@ €19.63XXXXISIN US3984384087CNMV:2020034915
Canonical exit: 25 Jun 2020 (T+90)
5,125 shares@ €19.80XXXXISIN US3984384087CNMV:2020034931
Canonical exit: 26 Jun 2020 (T+90)
26,529 shares@ €18.26ShareXXXXISIN ES0171996095CNMV:2020027608
12,306 shares@ €17.13ShareXXXXISIN ES0171996095CNMV:2020027617
11 of 11 declarations
About Grifols, S.A
Grifols, S.A is a Spanish company specializing in the production of plasma-derived products and intravenous solutions. It is listed on the Spanish stock market, XMAD.
